-
Mashup Score: 31Convalescent plasma cuts death by 10% in COVID patients on mechanical ventilation, trial finds - 6 month(s) ago
University of Minnesota http://twin-cities.umn.edu/ 612-625-5000 A randomized clinical trial in Belgium finds that convalescent plasma reduces death rates by about 10% in COVID-19 patients requiring invasive mechanical ventilation. University of Liege researchers led the open-label study involving 17 intensive care units (ICUs) in Belgium from October 2020 to March 2022, largely pre-Omicron strain. The results were published today in the New England Journal of Medicine. A total of 475 COVID-19 patients
Source: www.cidrap.umn.eduCategories: General Medicine News, Infectious DiseaseTweet
-
Mashup Score: 30Convalescent plasma cuts death by 10% in COVID patients on mechanical ventilation, trial finds - 6 month(s) ago
University of Minnesota http://twin-cities.umn.edu/ 612-625-5000 A randomized clinical trial in Belgium finds that convalescent plasma reduces death rates by about 10% in COVID-19 patients requiring invasive mechanical ventilation. University of Liege researchers led the open-label study involving 17 intensive care units (ICUs) in Belgium from October 2020 to March 2022, largely pre-Omicron strain. The results were published today in the New England Journal of Medicine. A total of 475 COVID-19 patients
Source: www.cidrap.umn.eduCategories: General Medicine News, Infectious DiseaseTweet-
#Convalescent plasma cuts death by 10% in COVID patients on mechanical ventilation, trial finds The effect was especially pronounced in those given convalescent plasma within the first 48 hours of mechanical ventilation. https://t.co/d8QxOyaUYS https://t.co/LcsJPkE30u
-
-
Mashup Score: 0Convalescent plasma for people with COVID‐19: a living systematic review - Iannizzi, C - 2023 | Cochrane Library - 12 month(s) ago
Collapse all Expand all Background Convalescent plasma may reduce mortality in patients with viral respiratory diseases, and is being investigated as a potential therapy for coronavirus disease 2019 (COVID‐19). A thorough understanding of the current body of evidence regarding benefits and risks of this intervention is required. Objectives To assess the effectiveness and safety of…
Source: www.cochranelibrary.comCategories: Latest Headlines, PulmonologyTweet-
#Convalescent #plasma for people with #COVID19: a living systematic #review https://t.co/ZGXVlKqNcm https://t.co/bDYuHYMm33
-
-
Mashup Score: 3
The pandemic COVID-19 has spread widely throughout the globe and has been responsible for millions of deaths worldwide. Recently it has been identifie…
Source: www.sciencedirect.comCategories: Latest Headlines, PulmonologyTweet-
#Convalescent #plasma (#hyperimmune #immunoglobulin) for #COVID-19 #management: An update https://t.co/oNiLUJeFei https://t.co/21Qknf99zM
-
-
Mashup Score: 0A Convincing Case for Convalescent Plasma Treatment of COVID-19 - 2 year(s) ago
Evidence for using antibody-rich convalescent plasma in early, outpatient treatment of COVID-19 is described as “solid.”
Source: Contagion LiveCategories: Infectious Disease, Latest HeadlinesTweet-
Placebo-controlled trial in outpatients with #COVID19 found early administration of #convalescent #plasma reduced #hospitalizations https://t.co/sOnOSqEcKs
-
-
Mashup Score: 0
Tocilizumab plus glucocorticoids is beneficial for patients with COVID-19 who require oxygen therapy, according to updated EULAR “points to consider” on the use of immunomodulatory therapies in SARS-CoV-2. The 2021 update also states that anti-SARS-CoV-2 monoclonal antibodies and convalescent plasma may be useful in early phases of the disease and in certain immunosuppressed patients.
Source: www.healio.comCategories: Latest Headlines, RheumatologyTweet-
New data made it possible for #EULAR "to formulate statements in favor of #tocilizumab in combination with #glucocorticoids and against #convalescent #plasma” for treatment of #COVID19 https://t.co/P76IA7YZdS
-
-
Mashup Score: 3Active surveillance of serious adverse events following transfusion of COVID‐19 convalescent plasma - 3 year(s) ago
Background The reported incidence of adverse reactions following Coronavirus disease 2019 (COVID-19) convalescent plasma (CCP) transfusion has generally been lower than expected based on the inciden…
Source: Wiley Online LibraryCategories: Hematologists1, Latest HeadlinesTweet-
Proud to share our report on the @StanfordMed experience with #COVID19 #convalescent plasma. Work lead by #transfusion fellow Erica Swenson and resident Lisa Wong. A great collaboration @StanfordPath @StanfordDOM @giveblood. https://t.co/SoriJWIQp8
-
-
Mashup Score: 1
Patients who received the therapy had half the rate of mortality at 28 days after treatment.
Source: Contagion LiveCategories: Infectious Disease, Latest HeadlinesTweet-
"We should not close the door prematurely on research into the therapeutic value of #convalescent #plasma research for severe #COVID19." https://t.co/WK5R7Mg8IJ
-
-
Mashup Score: 1Treating COVID-19 with Potent Neutralizing Antibodies - 3 year(s) ago
Convalescent plasma treatment was found not to improve survival or disease course in the patient group.
Source: Contagion LiveCategories: Infectious Disease, Latest HeadlinesTweet-
"The variable effectivity observed in trials on #convalescent plasma for #COVID19 may be explained by the timing of treatment and varying levels of preexisting immunity." #CROI2021 https://t.co/FeoKliVd8U
-
-
Mashup Score: 4FDA Updates its EUA for Convalescent Plasma - 3 year(s) ago
The agency limited it Emergency Use Authorization (EUA) for the COVID-19 therapy to the use of high titer COVID-19 convalescent plasma only for the treatment of hospitalized patients early in the disease. FDA is no longer authorizing the use of low-titer plasma in its EUA due to a lack of efficaciousness in further studies.
Source: Contagion LiveCategories: Infectious Disease, Latest HeadlinesTweet-
#FDA limited it EUA to the use of high titer #convalescent #plasma only for the treatment of hospitalized #COVID19 patients early in the disease. FDA is no longer authorizing the use of low-titer plasma in its EUA. https://t.co/t6lQZ22v6Y
-
#Convalescent plasma cuts death by 10% in COVID patients on mechanical ventilation, trial finds The effect was especially pronounced in those given convalescent plasma within the first 48 hours of mechanical ventilation. https://t.co/d8QxOyaUYS https://t.co/LcsJPkE30u